The U.S. Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract to Coherus Biosciences, Inc. for the procurement of Pegfilgrastim, a pharmaceutical product. The contract is valued at a ceiling of $27,626,788.30 and has a period of performance from April 11, 2025 to April 10, 2026, with four one-year option periods.
The purpose of this contract is to provide an uninterrupted supply of Pegfilgrastim to the VA, including its Consolidated Mail Order Pharmacies and State Veterans Homes, as well as the Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The solicitation was issued in a commercial item format, with an estimated annual usage of 8,458 units in the form of syringes or autoinjectors. This contract is open to all responsible sources, with no set-aside designation.
Generated 1/24/25, 9:06 AM